Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sanofi SA (SNY) vs Upwork Inc (UPWK) Price & Performance

Upwork IncTrade

Price performance (Past 24H)

Key statistics

Sanofi SA vs Upwork Inc — how do they compare? Sanofi SA trades at $40.07 (market cap $95.18B), while Upwork Inc trades at $8.6 (market cap $1.07B). The key difference: Sanofi SA is far larger — about 89× Upwork Inc's market cap, and Sanofi SA pays a 6.01% dividend while Upwork Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sanofi SA for 94 Days and Upwork Inc for 38 Days on average.

SNYUPWK
Market Cap
$95.18B$1.07B
Volume
2,995,6462,574,130
Sector
HealthIndustrials
52-Week High
$52.34$22.11
52-Week Low
$39.51$7.84
Typical Hold Time
94 Days38 Days
Enterprise Value
$114.48B$833.01M
Dividend Yield
6.01%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sanofi SA

Sanofi (SNY) trades at $40.23, up 0.07% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q2 2026 earnings beat with EPS of $1.21 versus $1.10 expected, continuing a trend of exceeding expectations. Recent expansion of the immunology alliance with Regeneron adds potential for future growth through new antibody programs.

While valuation metrics appear reasonable with P/E of 22.14 and P/S of 1.77, projected 2026 net income decline to $4.0B (8.09% margin) raises concerns. Analyst consensus leans cautious with 44% buy ratings versus 52% hold, suggesting tempered optimism despite recent positive developments.

Upwork Inc

UPWK trades at $8.57, up 2.02% today, with a bearish technical signal from moving averages and RSI near overbought levels. The company reported mixed Q2 2026 earnings, beating EPS estimates but missing on revenue guidance, leading to a recent stock decline. Fundamentals show strong profitability with a 77.21% gross margin and 12.93% net income margin, while valuation ratios like P/E of 10.99 and P/S of 1.48 appear reasonable. Recent news highlights insider selling and ongoing securities fraud investigations.

The outlook for UPWK is cautious due to AI-driven competitive threats and weak guidance, though low valuation provides downside protection. Risks include declining active clients and legal scrutiny, but analyst consensus remains bullish with a $9.64 price target. Investment opportunity hinges on execution amid industry disruption.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SNY
35% Buy65% Sell
Avg holding period · 94 Days
UPWK

No sentiment data available yet.

Top news

Latest headlines on both assets

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY →

About Upwork Inc

Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.

Read more on UPWK →